Hepatitis Forums

Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on June 10, 2019, 10:52:13 am

Title: Hep C Treatment Tied to Lower Risk of Liver Cancer and Death From Any Cause
Post by: Hep Editors on June 10, 2019, 10:52:13 am

Direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) is associated with lower risks of hepatocellular carcinoma (HCC, the most common form of liver cancer) and death from any cause, Infectious Disease Advisor reports.

Publishing their findings in The Lancet, researchers screened 10,166 people with hep C in 32 French hepatology centers between August 2012 and December 2015. The study excluded those with hepatitis B virus, a history of decompensated cirrhosis (the more advanced form of the severe liver disease), a history of liver cancer, a history of liver transplantation and those previously treated with interferon and ribavirin.

Read more...
https://www.hepmag.com/article/hep-c-treatment-tied-lower-risk-liver-cancer-death-cause